Delivery Order SPE2DB22D1017-SPE2DB24FF1FT
Award Date 1/12/24
Potential Completion Date 1/16/24
Potential Value $5.2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $65,411.87 to provide 4,564,298,844 capsules of Tamsulosin HCL 0.4 mg. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 17, 2024. The contract is a firm fixed-price arrangement, without any set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc. This...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,610,559 capsules of Tamsulosin HCl 0.4 mg. The contract has a completion date of February 12, 2024 and a potential value of $2,459.44. This award is under a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a maximum potential value of $999,999,999.00 through December 31,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a leading pharmaceutical distributor, for the delivery of 4,565,892,103 capsules of Tamsulosin Hydrochloride 0.4 milligram. The contract is a firm fixed-price delivery order with a ceiling value of $23,865.04 and a period of performance through September 23, 2024. Amerisourcebergen, through its Corporate Office division, will supply this critical medication to support military treatment...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,561,823,091 units of Tamsulosin HCL 0.4 mg capsules. The contract has a firm fixed price of $5,949.44 and an ultimate completion date of August 16, 2023. The contract was awarded on August 15, 2023 and was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,703.94, is a delivery order for the supply of 1,000 capsules of the medication Tamsulosin Hydrochloride 0.4 mg. The contract is a firm fixed-price agreement with a completion date of May 14, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not set aside for any...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, for the delivery of 4,563,590,294 units of Tamsulosin HCL 0.4 mg capsules. The firm-fixed-price delivery order, valued at $4,909.85, has a completion date of February 8, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a $999,999,999 Indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,001,477 capsules of the generic drug tamsulosin hydrochloride 0.4 mg. The $3,324.39 contract has a performance period through March 19, 2024. AmerisourceBergen Drug Corp is the prime contractor and no set-aside designation was used. This award is associated with a larger indefinite delivery contract between...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,081.48 firm fixed-price delivery order is for the supply of 4,565,546,920 units of Tamsulosin Hydrochloride 0.4 mg capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of medical commodities from...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,060.04 Firm Fixed Price Delivery Order is for the supply of 4,563,337,812 units of the drug Tamsulosin HCL 0.4 mg capsules. The contract has an ultimate completion date of January 17, 2024. This award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC)...
- The federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,437.67, is for the delivery of 4,567,253 units of Tamsulosin HCL 0.4 mg capsules. This is a Firm Fixed Price Delivery Order contract with a completion date of February 13, 2025. The contract is not designated with a set-aside. Amerisourcebergen holds a significant...